ADMP Annual FCF
-$26.58 M
+$12.43 M+31.86%
31 December 2022
Summary:
As of February 2, 2025, ADMP annual free cash flow is -$26.58 million, with the most recent change of +$12.43 million (+31.86%) on December 31, 2022. During the last 3 years, it has fallen by -$3.83 million (-16.83%).ADMP Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ADMP Quarterly FCF
-$2.57 M
-$1.02 M-65.98%
30 June 2023
Summary:
As of February 2, 2025, ADMP quarterly free cash flow is -$2.57 million, with the most recent change of -$1.02 million (-65.98%) on June 30, 2023. Over the past year, it has increased by +$7.68 million (+74.94%).ADMP Quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ADMP TTM FCF
-$13.44 M
+$7.68 M+36.37%
30 June 2023
Summary:
As of February 2, 2025, ADMP TTM free cash flow is -$13.44 million, with the most recent change of +$7.68 million (+36.37%) on June 30, 2023. Over the past year, it has increased by +$20.64 million (+60.58%).ADMP TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ADMP Free Cash Flow Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +31.9% | +74.9% | +60.6% |
| 3 y3 years | -16.8% | +55.5% | +26.0% |
| 5 y5 years | -54.4% | +53.5% | +41.0% |
ADMP Free Cash Flow High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | ||||||
| 5 y | 5-year | ||||||
| alltime | all time | -3144.8% | -120.4% | -409.2% |
Adamis Pharmaceuticals Free Cash Flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2023 | - | -$2.57 M(+66.0%) | -$13.44 M(-36.4%) |
| Mar 2023 | - | -$1.55 M(-4.1%) | -$21.12 M(-20.6%) |
| Dec 2022 | -$26.58 M(-31.9%) | -$1.61 M(-79.1%) | -$26.58 M(-16.6%) |
| Sept 2022 | - | -$7.71 M(-24.8%) | -$31.87 M(-6.5%) |
| June 2022 | - | -$10.25 M(+46.1%) | -$34.08 M(-17.0%) |
| Mar 2022 | - | -$7.01 M(+1.6%) | -$41.08 M(+5.3%) |
| Dec 2021 | -$39.01 M(+80.6%) | -$6.90 M(-30.4%) | -$39.01 M(+4.1%) |
| Sept 2021 | - | -$9.92 M(-42.5%) | -$37.49 M(+11.9%) |
| June 2021 | - | -$17.25 M(+249.0%) | -$33.50 M(+52.1%) |
| Mar 2021 | - | -$4.94 M(-8.2%) | -$22.03 M(+2.0%) |
| Dec 2020 | -$21.60 M(-5.1%) | -$5.38 M(-9.3%) | -$21.60 M(+11.0%) |
| Sept 2020 | - | -$5.93 M(+2.7%) | -$19.46 M(+7.2%) |
| June 2020 | - | -$5.78 M(+28.0%) | -$18.15 M(+4.7%) |
| Mar 2020 | - | -$4.51 M(+39.3%) | -$17.33 M(-23.8%) |
| Dec 2019 | -$22.75 M(-37.1%) | -$3.24 M(-29.9%) | -$22.75 M(-29.2%) |
| Sept 2019 | - | -$4.62 M(-6.8%) | -$32.15 M(-14.1%) |
| June 2019 | - | -$4.95 M(-50.2%) | -$37.42 M(-1.5%) |
| Mar 2019 | - | -$9.94 M(-21.4%) | -$37.98 M(+4.9%) |
| Dec 2018 | -$36.19 M(+110.2%) | -$12.64 M(+27.9%) | -$36.19 M(+23.1%) |
| Sept 2018 | - | -$9.88 M(+79.0%) | -$29.41 M(+26.2%) |
| June 2018 | - | -$5.52 M(-32.3%) | -$23.29 M(+6.8%) |
| Mar 2018 | - | -$8.15 M(+39.2%) | -$21.82 M(+26.7%) |
| Dec 2017 | -$17.22 M(-19.1%) | -$5.85 M(+55.2%) | -$17.22 M(+16.7%) |
| Sept 2017 | - | -$3.77 M(-6.7%) | -$14.76 M(-16.8%) |
| June 2017 | - | -$4.04 M(+13.6%) | -$17.73 M(-12.1%) |
| Mar 2017 | - | -$3.56 M(+4.9%) | -$20.17 M(-5.2%) |
| Dec 2016 | -$21.28 M(+105.9%) | -$3.39 M(-49.7%) | -$21.28 M(+5.8%) |
| Sept 2016 | - | -$6.74 M(+4.0%) | -$20.12 M(+29.6%) |
| June 2016 | - | -$6.48 M(+38.8%) | -$15.53 M(+31.2%) |
| Mar 2016 | - | -$4.67 M(+109.5%) | -$11.83 M(+14.5%) |
| Dec 2015 | -$10.34 M(+61.2%) | -$2.23 M(+3.9%) | -$10.34 M(+27.5%) |
| Sept 2015 | - | -$2.15 M(-23.1%) | -$8.11 M(+12.4%) |
| June 2015 | - | -$2.79 M(-12.1%) | -$7.21 M(+1.9%) |
| Mar 2015 | - | -$3.17 M(+154.1%) | -$7.08 M(-62.2%) |
| Dec 2014 | -$6.41 M(-61.8%) | - | - |
| Sept 2014 | - | -$1.25 M(-53.0%) | -$18.70 M(+5.3%) |
| June 2014 | - | -$2.66 M(+13.5%) | -$17.76 M(+5.8%) |
| Mar 2014 | -$16.78 M(+555.7%) | -$2.34 M(-81.2%) | -$16.78 M(+16.1%) |
| Dec 2013 | - | -$12.46 M(+4022.4%) | -$14.46 M(+454.3%) |
| Sept 2013 | - | -$302.20 K(-82.0%) | -$2.61 M(-13.5%) |
| June 2013 | - | -$1.68 M(+9611.0%) | -$3.02 M(+17.9%) |
| Mar 2013 | -$2.56 M(-23.5%) | -$17.30 K(-97.2%) | -$2.56 M(-19.7%) |
| Dec 2012 | - | -$608.70 K(-14.3%) | -$3.19 M(-3.0%) |
| Sept 2012 | - | -$710.00 K(-42.0%) | -$3.29 M(-2.3%) |
| June 2012 | - | -$1.22 M(+89.2%) | -$3.37 M(+0.6%) |
| Mar 2012 | -$3.35 M(-22.3%) | -$646.40 K(-8.8%) | -$3.35 M(-15.3%) |
| Dec 2011 | - | -$708.60 K(-10.1%) | -$3.95 M(-27.7%) |
| Sept 2011 | - | -$788.20 K(-34.5%) | -$5.46 M(+7.3%) |
| June 2011 | - | -$1.20 M(-3.7%) | -$5.09 M(+18.2%) |
| Mar 2011 | -$4.31 M(+115.0%) | -$1.25 M(-43.9%) | -$4.31 M(-1.1%) |
| Dec 2010 | - | -$2.22 M(+436.6%) | -$4.36 M(+66.8%) |
| Sept 2010 | - | -$414.60 K(-1.0%) | -$2.61 M(+20.8%) |
| June 2010 | - | -$418.90 K(-67.7%) | -$2.16 M(+7.9%) |
| Mar 2010 | -$2.00 M | -$1.30 M(+170.1%) | -$2.00 M(+160.2%) |
| Dec 2009 | - | -$480.50 K(-1453.5%) | -$769.90 K(+47.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2009 | - | $35.50 K(-113.6%) | -$520.90 K(-37.3%) |
| June 2009 | - | -$260.90 K(+307.7%) | -$830.40 K(-2.0%) |
| Mar 2009 | - | -$64.00 K(-72.4%) | -$847.50 K(-29.2%) |
| Dec 2008 | -$1.20 M(-38.2%) | -$231.50 K(-15.5%) | -$1.20 M(-6.0%) |
| Sept 2008 | - | -$274.00 K(-1.4%) | -$1.27 M(-8.1%) |
| June 2008 | - | -$278.00 K(-32.9%) | -$1.39 M(-19.7%) |
| Mar 2008 | - | -$414.00 K(+34.3%) | -$1.73 M(-10.9%) |
| Dec 2007 | -$1.94 M(-61.6%) | -$308.20 K(-20.2%) | -$1.94 M(-36.7%) |
| Sept 2007 | - | -$386.00 K(-37.5%) | -$3.06 M(-18.3%) |
| June 2007 | - | -$618.00 K(-1.1%) | -$3.75 M(-19.7%) |
| Mar 2007 | - | -$625.00 K(-56.4%) | -$4.67 M(-7.5%) |
| Dec 2006 | -$5.04 M(-70.0%) | -$1.43 M(+33.5%) | -$5.04 M(-37.6%) |
| Sept 2006 | - | -$1.07 M(-30.1%) | -$8.08 M(-8.8%) |
| June 2006 | - | -$1.54 M(+53.4%) | -$8.86 M(-30.9%) |
| Mar 2006 | - | -$1.00 M(-77.6%) | -$12.81 M(-23.9%) |
| Dec 2005 | -$16.83 M(+21.9%) | -$4.47 M(+141.6%) | -$16.83 M(-5.1%) |
| Sept 2005 | - | -$1.85 M(-66.3%) | -$17.74 M(-3.1%) |
| June 2005 | - | -$5.49 M(+9.3%) | -$18.31 M(+16.6%) |
| Mar 2005 | - | -$5.02 M(-6.6%) | -$15.70 M(+13.7%) |
| Dec 2004 | -$13.80 M(+7.3%) | -$5.37 M(+121.9%) | -$13.80 M(+21.8%) |
| Sept 2004 | - | -$2.42 M(-15.9%) | -$11.33 M(-5.9%) |
| June 2004 | - | -$2.88 M(-7.9%) | -$12.05 M(-4.2%) |
| Mar 2004 | - | -$3.13 M(+7.7%) | -$12.58 M(-2.2%) |
| Dec 2003 | -$12.87 M(-1574.1%) | -$2.90 M(-7.5%) | -$12.87 M(-593.6%) |
| Sept 2003 | - | -$3.14 M(-8.0%) | $2.61 M(-40.0%) |
| June 2003 | - | -$3.41 M(-0.1%) | $4.34 M(+87.0%) |
| Mar 2003 | - | -$3.41 M(-127.2%) | $2.32 M(+166.1%) |
| Dec 2002 | $873.00 K(-106.6%) | $12.57 M(-997.4%) | $873.00 K(-106.1%) |
| Sept 2002 | - | -$1.40 M(-74.2%) | -$14.39 M(-11.7%) |
| June 2002 | - | -$5.43 M(+11.7%) | -$16.29 M(+5.7%) |
| Mar 2002 | - | -$4.86 M(+80.9%) | -$15.41 M(+16.4%) |
| Dec 2001 | -$13.24 M(+41.1%) | -$2.69 M(-18.7%) | -$13.24 M(+4.0%) |
| Sept 2001 | - | -$3.31 M(-27.3%) | -$12.73 M(+1.8%) |
| June 2001 | - | -$4.55 M(+69.1%) | -$12.51 M(+17.7%) |
| Mar 2001 | - | -$2.69 M(+23.6%) | -$10.63 M(+13.2%) |
| Dec 2000 | -$9.38 M(-8.9%) | -$2.18 M(-29.5%) | -$9.38 M(+0.8%) |
| Sept 2000 | - | -$3.09 M(+15.7%) | -$9.31 M(+8.1%) |
| June 2000 | - | -$2.67 M(+84.2%) | -$8.61 M(+3.1%) |
| Mar 2000 | - | -$1.45 M(-31.0%) | -$8.35 M(-18.9%) |
| Dec 1999 | -$10.30 M(+3.0%) | -$2.10 M(-12.1%) | -$10.30 M(-16.3%) |
| Sept 1999 | - | -$2.39 M(-0.8%) | -$12.30 M(+4.1%) |
| June 1999 | - | -$2.41 M(-29.1%) | -$11.81 M(+1.8%) |
| Mar 1999 | - | -$3.40 M(-17.1%) | -$11.60 M(+16.0%) |
| Dec 1998 | -$10.00 M(+185.7%) | -$4.10 M(+115.8%) | -$10.00 M(+37.0%) |
| Sept 1998 | - | -$1.90 M(-13.6%) | -$7.30 M(+25.9%) |
| June 1998 | - | -$2.20 M(+22.2%) | -$5.80 M(+31.8%) |
| Mar 1998 | - | -$1.80 M(+28.6%) | -$4.40 M(+25.7%) |
| Dec 1997 | -$3.50 M(+6.1%) | -$1.40 M(+250.0%) | -$3.50 M(+52.2%) |
| Sept 1997 | - | -$400.00 K(-50.0%) | -$2.30 M(-25.8%) |
| June 1997 | - | -$800.00 K(-11.1%) | -$3.10 M(0.0%) |
| Mar 1997 | - | -$900.00 K(+350.0%) | -$3.10 M(-6.1%) |
| Dec 1996 | -$3.30 M(+22.2%) | -$200.00 K(-83.3%) | -$3.30 M(+6.5%) |
| Sept 1996 | - | -$1.20 M(+50.0%) | -$3.10 M(+63.2%) |
| June 1996 | - | -$800.00 K(-27.3%) | -$1.90 M(+72.7%) |
| Mar 1996 | - | -$1.10 M | -$1.10 M |
| Dec 1995 | -$2.70 M | - | - |
FAQ
- What is Adamis Pharmaceuticals annual free cash flow?
- What is the all time high annual FCF for Adamis Pharmaceuticals?
- What is Adamis Pharmaceuticals annual FCF year-on-year change?
- What is Adamis Pharmaceuticals quarterly free cash flow?
- What is the all time high quarterly FCF for Adamis Pharmaceuticals?
- What is Adamis Pharmaceuticals quarterly FCF year-on-year change?
- What is Adamis Pharmaceuticals TTM free cash flow?
- What is the all time high TTM FCF for Adamis Pharmaceuticals?
- What is Adamis Pharmaceuticals TTM FCF year-on-year change?
What is Adamis Pharmaceuticals annual free cash flow?
The current annual FCF of ADMP is -$26.58 M
What is the all time high annual FCF for Adamis Pharmaceuticals?
Adamis Pharmaceuticals all-time high annual free cash flow is $873.00 K
What is Adamis Pharmaceuticals annual FCF year-on-year change?
Over the past year, ADMP annual free cash flow has changed by +$12.43 M (+31.86%)
What is Adamis Pharmaceuticals quarterly free cash flow?
The current quarterly FCF of ADMP is -$2.57 M
What is the all time high quarterly FCF for Adamis Pharmaceuticals?
Adamis Pharmaceuticals all-time high quarterly free cash flow is $12.57 M
What is Adamis Pharmaceuticals quarterly FCF year-on-year change?
Over the past year, ADMP quarterly free cash flow has changed by +$7.68 M (+74.94%)
What is Adamis Pharmaceuticals TTM free cash flow?
The current TTM FCF of ADMP is -$13.44 M
What is the all time high TTM FCF for Adamis Pharmaceuticals?
Adamis Pharmaceuticals all-time high TTM free cash flow is $4.34 M
What is Adamis Pharmaceuticals TTM FCF year-on-year change?
Over the past year, ADMP TTM free cash flow has changed by +$20.64 M (+60.58%)